Mitotax 30mg Injection is a vital chemotherapeutic agent used in the treatment of various cancers. Its active ingredient, Paclitaxel, belongs to the taxane class of drugs. Paclitaxel works by disrupting the normal functioning of microtubules, which are essential components of cell division. By stabilizing microtubules, it prevents the breakdown of the mitotic spindle, thereby arresting cells in the M phase of the cell cycle and ultimately leading to cell death. This mechanism makes it effective against rapidly dividing cancer cells.
Mitotax 30mg Injection is indicated for the treatment of advanced ovarian cancer, breast cancer, and non-small cell lung cancer. It may also be used in combination with other chemotherapy drugs. The dosage and duration of treatment are determined by the patient’s medical condition, the type and stage of cancer, and their response to therapy. It is administered intravenously by a qualified healthcare professional.
Common side effects may include bone marrow suppression (leading to low blood cell counts), peripheral neuropathy (numbness or tingling in hands and feet), hair loss, nausea, vomiting, diarrhea, and allergic reactions. Patients should be closely monitored for these side effects. Mitotax 30mg Injection should be stored at room temperature, protected from light, and should not be frozen.
